| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |